Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-047299
Filing Date
2010-05-10
Accepted
2010-05-10 17:04:51
Documents
9
Period of Report
2010-04-04

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y83341e10vq.htm 10-Q 320801
2 EX-31.1 y83341exv31w1.htm EX-31.1 11720
3 EX-32.1 y83341exv32w1.htm EX-32.1 6783
9 GRAPHIC y83341y8334101.gif GRAPHIC 3717
  Complete submission text file 0000950123-10-047299.txt   1869986

Data Files

Seq Description Document Type Size
4 EX-101 INSTANCE DOCUMENT jnj-20100404.xml EX-101.INS 276211
5 EX-101 SCHEMA DOCUMENT jnj-20100404.xsd EX-101.SCH 14194
6 EX-101 CALCULATION LINKBASE DOCUMENT jnj-20100404_cal.xml EX-101.CAL 38159
7 EX-101 LABELS LINKBASE DOCUMENT jnj-20100404_lab.xml EX-101.LAB 152005
8 EX-101 PRESENTATION LINKBASE DOCUMENT jnj-20100404_pre.xml EX-101.PRE 79184
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0209
Type: 10-Q | Act: 34 | File No.: 001-03215 | Film No.: 10817216
SIC: 2834 Pharmaceutical Preparations